“Breakthrough” Psilocybin compound fast-tracked by FDA

FDA gives psilocybin a major boost The process of having a new drug be approved is understandably slow but also quite frustrating, in rare form, the FDA (US Food & Drug Administration) has granted a clinical trial on Psilocybin, a hallucinogenic substance found in magic mushrooms and truffles alike, “breakthrough therapy” designation for the second […]